AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments.
Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals.
Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging.
The company was founded in 1988 and is based in White Plains, New York.
Country | United States |
IPO Date | May 19, 2021 |
Industry | Software - Application |
Sector | Technology |
Employees | 284 |
CEO | Michel Brousset |
Contact Details
Address: 10 Bank Street White Plains, New York United States | |
Website | http://www.waldencast.com |
Stock Details
Ticker Symbol | WALDW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001840199 |
CUSIP Number | G9503X111 |
ISIN Number | JE00BPG9B357 |
Employer ID | 00-0000000 |
SIC Code | 2844 |
Key Executives
Name | Position |
---|---|
Michel Brousset | Founder, Chief Executive Officer & Director |
Manuel Manfredi | Chief Financial Officer |
Elisabeth Milan | General Counsel |
Hind Sebti | Co-Founder, Chief Growth Officer & Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 21, 2024 | 6-K | Filing |
Nov 20, 2024 | 6-K | Filing |
Nov 20, 2024 | 20-F/A | [Amend] Filing |
Nov 13, 2024 | 6-K | Filing |
Oct 30, 2024 | 6-K | Filing |
Oct 07, 2024 | 6-K | Filing |
Aug 28, 2024 | 6-K | Filing |
Aug 27, 2024 | 6-K | Filing |
Aug 27, 2024 | 6-K | Filing |
Aug 21, 2024 | 6-K | Filing |